Related Experiment Video
Updated: May 12, 2026

The WATCHMAN Left Atrial Appendage Closure Device for Atrial Fibrillation
Published on: February 28, 2012
Combining catheter ablation and left atrial appendage occlusion in high-risk patients with atrial fibrillation: a
Ziyong Hao1, Bin Liu1, Xiaoyi Xie2
1Department of Cardiology, Shanghai Chest Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China.
Insights
Combining catheter ablation (CA) with left atrial appendage occlusion (LAAO) is safe for atrial fibrillation (AF) patients. This approach may reduce heart failure hospitalizations, though it increases peri-device leaks.
Area of Science:
- Cardiology
- Interventional Cardiology
- Electrophysiology
Background:
- The combined safety and efficacy of catheter ablation (CA) and left atrial appendage occlusion (LAAO) versus LAAO alone for atrial fibrillation (AF) patients is not well-established.
- Patients with AF and increased stroke risk undergoing LAAO were evaluated.
Purpose of the Study:
- To compare the safety and efficacy of a combined CA and LAAO approach versus LAAO alone in AF patients.
- To assess a composite endpoint including death, thromboembolic events, major bleeding, heart failure (HF) rehospitalization, and periprocedural complications.
Main Methods:
- A total of 707 AF patients undergoing LAAO were analyzed.
- Propensity score matching created two groups: LAAO alone (83 patients) and combined CA and LAAO (83 patients).
- The primary endpoint was a composite of death, thromboembolic events, major bleeding, HF rehospitalization, and major periprocedural complications, with a median follow-up of 2 years.
Main Results:
- Successful LAAO was achieved in all patients, with similar low periprocedural complication rates (2.4% vs. 4.8%).
- Peri-device leak was significantly higher in the combined group (25.3% vs. 43.4%, p=0.01).
- No significant difference was observed in the primary composite endpoint between groups (22.2% vs. 14.3%, p=0.63), but HF rehospitalization was significantly lower in the combined group (19.6% vs. 3.6%, p=0.024).
Conclusions:
- A combined CA and LAAO "one-stop" approach is safe for AF patients.
- This combined strategy offers additional benefits in reducing heart failure symptoms and hospitalizations.
- Increased incidence of peri-device leak is a consideration when combining CA and LAAO.
Background:
The safety and efficacy of a combined approach of catheter ablation (CA) and left atrial appendage occlusion (LAAO) compared to LAAO alone remain unknown.
Methods:
Patients with atrial fibrillation (AF) at increased stroke risk who underwent LAAO were divided into either combined (CA and LAAO) procedures or LAAO alone group. Propensity score matching was utilized to balance baseline characteristics. The primary endpoint of the study was a composite of death, thromboembolic events, major bleeding, heart failure (HF) rehospitalization, and major periprocedural complications.
Results:
A total of 707 AF patients who underwent LAAO were included. After 1:1 propensity score matching, 166 patients who underwent LAAO alone (n = 83) or the combined procedure (n = 83) were analyzed. Successful LAAO was achieved in all (100%) patients, with a low incidence of periprocedural complications in both groups (2.4% vs. 4.8%, LAAO vs. combined, p = 0.68). The incidence of peri-device leak post-LAAO was significantly higher in the combined group (25.3% vs. 43.4%, p = 0.01). After a median follow-up of 2 years, there were no significant differences in the rates of the primary composite endpoint between the two strategies (22.2% vs. 14.3%, HR: 1.24 [95% CI: 0.51-2.97], p = 0.63). However, the rate of HF rehospitalization was significantly lower in the combined group (19.6% vs. 3.6%, HR: 4.89 [95% CI: 1.50-15.97], p = 0.024).
Conclusions:
Combining CA and LAAO in a "one-stop" approach is safe and brings additional benefits in relieving symptoms of heart failure, although peri-device leak was more common compared to LAAO alone.
Related Concept Videos
Mitral Regurgitation I: Introduction
Mitral Stenosis I: Introduction
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy V: Interprofessional Care

